253 related articles for article (PubMed ID: 27357360)
21. Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.
Nakaguro M; Kiyonari S; Kishida S; Cao D; Murakami-Tonami Y; Ichikawa H; Takeuchi I; Nakamura S; Kadomatsu K
Cancer Sci; 2015 Mar; 106(3):237-43. PubMed ID: 25557119
[TBL] [Abstract][Full Text] [Related]
22. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma.
Chen ST; Jeng YM; Chang CC; Chang HH; Huang MC; Juan HF; Hsu CH; Lee H; Liao YF; Lee YL; Hsu WM; Lai HS
Cancer Sci; 2011 Dec; 102(12):2191-8. PubMed ID: 21917080
[TBL] [Abstract][Full Text] [Related]
24. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
25. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485
[TBL] [Abstract][Full Text] [Related]
26. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
[TBL] [Abstract][Full Text] [Related]
27. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
28. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.
Hossain MS; Ozaki T; Wang H; Nakagawa A; Takenobu H; Ohira M; Kamijo T; Nakagawara A
Oncogene; 2008 Oct; 27(46):6075-82. PubMed ID: 18591937
[TBL] [Abstract][Full Text] [Related]
29. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
Yco LP; Geerts D; Koster J; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
[TBL] [Abstract][Full Text] [Related]
30. ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression.
Watanabe Y; Ishizuka Y; Hirano T; Nagasaki-Maeoka E; Hoshi R; Yoshizawa S; Uekusa S; Kawashima H; Sugito K; Shinohara K; Fukuda N; Nagase H; Soma M; Koshinaga T; Fujiwara K
Med Oncol; 2017 Aug; 34(9):158. PubMed ID: 28791558
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation.
Song HY; Rellinger EJ; Park SH; Paul P; Qiao J; Vasilopoulos A; Ozden O; Gius D; Chung DH
Anticancer Res; 2018 Feb; 38(2):647-654. PubMed ID: 29374686
[TBL] [Abstract][Full Text] [Related]
32. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
Bui CB; Le HK; Vu DM; Truong KD; Nguyen NM; Ho MAN; Truong DQ
Mol Carcinog; 2019 Nov; 58(11):1998-2007. PubMed ID: 31365169
[TBL] [Abstract][Full Text] [Related]
33. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
34. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
Blanc E; Roux GL; Bénard J; Raguénez G
Oncogene; 2005 Feb; 24(7):1277-83. PubMed ID: 15592517
[TBL] [Abstract][Full Text] [Related]
35. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
36. Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.
Avci CB; Dodurga Y; Gundogdu G; Caglar HO; Kucukatay V; Gunduz C; Satiroglu-Tufan NL
Tumour Biol; 2013 Dec; 34(6):3853-7. PubMed ID: 23821302
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
[TBL] [Abstract][Full Text] [Related]
38. Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2.
Andersson G; Påhlman S; Parrow V; Johansson I; Hammerling U
Cell Growth Differ; 1994 Jan; 5(1):27-36. PubMed ID: 8123590
[TBL] [Abstract][Full Text] [Related]
39. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
[TBL] [Abstract][Full Text] [Related]
40. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
